Company Filing History:
Years Active: 2015
Title: Amanda Cobb: Innovator in Vaccine Development
Introduction
Amanda Cobb is a notable inventor based in Fort Worth, TX (US). She has made significant contributions to the field of vaccine development, particularly in the area of HIV research. Her innovative work has led to the creation of a unique vaccine that aims to elicit a robust immune response against HIV.
Latest Patents
Amanda Cobb holds a patent for a dendritic cell-specific antibody conjugate comprising anti-CD40 monoclonal antibodies conjugated to HIV-1 Gag/Nef. This invention includes compositions and methods for making and using a vaccine that incorporates a DC-specific antibody or fragment thereof. The engineered Gag antigen is designed to be less susceptible to proteolytic degradation, enhancing the vaccine's effectiveness. The vaccine aims to elicit an HIV-specific T cell immune response to Gag p17, Gag p24, Nef, and/or Cyclin D1. She has 1 patent to her name.
Career Highlights
Amanda Cobb is affiliated with the Baylor Research Institute, where she continues her research and development efforts. Her work is pivotal in advancing the understanding and treatment of HIV through innovative vaccine strategies.
Collaborations
Amanda has collaborated with esteemed colleagues such as Jacques F. Banchereau and Gerard Zurawski, contributing to the advancement of her research and the development of effective vaccine solutions.
Conclusion
Amanda Cobb's contributions to vaccine development, particularly in the context of HIV, highlight her role as an innovative inventor. Her work not only showcases her expertise but also represents a significant step forward in the fight against infectious diseases.